Market revenue in 2023 | USD 6.1 million |
Market revenue in 2030 | USD 7.7 million |
Growth rate | 3.5% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Illumina Inc, Roche Holding AG ADR, BD, Agilent Technologies Inc, Myriad Genetics Inc, Koninklijke Philips NV, Abbott Laboratories, Hitachi Ltd, Danaher Corp, Prestige Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer diagnostic market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 62.3% in 2023. Horizon Databook has segmented the Kuwait pancreatic cancer diagnostic market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait is one of the fastest-growing countries in MENA due to its increasing exports and growing economy. With major advancements in its healthcare infrastructure, the country is addressing the growing prevalence of infectious, chronic, and lifestyle-associated diseases.
Hence, the rising prevalence of target diseases in the country is a major factor expected to drive market growth over the forecast period. Kuwait is increasingly emphasizing early diagnosis and screening for a better treatment outlook.
Screening solutions have witnessed certain novel advancements, such as the adoption of advanced cancer diagnostic solutions and emphasis on precise diagnosis with increased usage of biomarkers. The efforts of government & nongovernment organizations to raise patient awareness and facilitate early detection are fueling the demand for new cancer screening technologies.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait pancreatic cancer diagnostic market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait pancreatic cancer diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account